title: Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.
authors.forename: Ya Mei
authors.initials: YM
authors.lastname: Bai
authors.forename: Tzu Ting
authors.initials: TT
authors.lastname: Chen
authors.forename: Wen Kuo
authors.initials: WK
authors.lastname: Lin
authors.forename: Wen-Ho
authors.initials: WH
authors.lastname: Chang
authors.forename: Bojian
authors.initials: B
authors.lastname: Wu
authors.forename: Chih Hung
authors.initials: CH
authors.lastname: Hung
authors.forename: Pesus
authors.initials: P
authors.lastname: Chou
authors.forename: Jen-Yeu
authors.initials: JY
authors.lastname: Chen
mesh_terms: D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D007273:Injections, Intramuscular; D018967:Risperidone / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*; D012559:Schizophrenia / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone